Literature DB >> 8994320

Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.

Y Men1, B Gander, H P Merkle, G Corradin.   

Abstract

Biodegradable microspheres (MS) based on poly(D,L-lactide) and poly(D,L-lactide-coglycolide) have the capacity to release encapsulated antigens over defined lengths of time depending on their composition and to elicit and sustain strong and long-lasting immune responses to protein antigens. In the present study, two synthetic multiple antigenic peptides (MAP), P30B2 and (NANP)6P2P30, were incorporated into MS of different compositions. P30B2 and (NANP)6P2P30 are composed of one or two universal T helper epitopes from tetanus toxin, 947-967 (P30) and 830-843 (P2), and of a B cell epitope derived from the repeat sequence of Plasmodium berghei or Plasmodium falciparum, respectively. BALB/c mice were immunized with these two peptides in different formulations, including individual MS or mixtures of MS with various release properties, Incomplete Freund's adjuvant (IFA) or as soluble peptides. MS formulations elicited strong and sustained proliferative and antibody responses comparable to those obtained with the IFA preparations. Furthermore, MS formulations induced specific isotype/ subclass antibodies similar to those induced by IFA. No significant augmentation of total serum IgE was detected during this study. In addition, a boosting effect was obtained when the immunized mice were reinjected with a small antigen dose in IFA several months later. These results indicate that biodegradable MS may be a suitable vaccine delivery system/adjuvant not only for protein antigens but also for weakly immunogenic synthetic peptides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8994320     DOI: 10.1016/s0264-410x(96)00074-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

Authors:  P Johansen; Y Men; R Audran; G Corradin; H P Merkle; B Gander
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

Review 2.  Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.

Authors:  Moses O Oyewumi; Amit Kumar; Zhengrong Cui
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

3.  Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.

Authors:  R Audran; Y Men; P Johansen; B Gander; G Corradin
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

4.  Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B.

Authors:  Dongmei Lu; Lucila Garcia-Contreras; Ding Xu; Sherry L Kurtz; Jian Liu; Miriam Braunstein; David N McMurray; Anthony J Hickey
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

5.  A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles.

Authors:  Julia M Martínez Gómez; Stefan Fischer; Noèmi Csaba; Thomas M Kündig; Hans P Merkle; Bruno Gander; Pål Johansen
Journal:  Pharm Res       Date:  2007-05-31       Impact factor: 4.200

6.  Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration.

Authors:  Angel M Carcaboso; Rosa M Hernández; Manuela Igartua; Jaiver E Rosas; Manuel E Patarroyo; José L Pedraz
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 7.  Pharmaceutical aerosols for the treatment and prevention of tuberculosis.

Authors:  Shumaila N M Hanif; Lucila Garcia-Contreras
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

8.  In Vivo Sustained Release of Peptide Vaccine Mediated by Dendritic Mesoporous Silica Nanocarriers.

Authors:  Weiteng An; Sira Defaus; David Andreu; Pilar Rivera-Gil
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

Review 9.  The Use of Synthetic Carriers in Malaria Vaccine Design.

Authors:  Liam Powles; Sue D Xiang; Cordelia Selomulya; Magdalena Plebanski
Journal:  Vaccines (Basel)       Date:  2015-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.